Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María Colazo-Burlato

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Rheumatology|May 14, 2013
Severe Guillain-Barré syndrome in a patient receiving anti-TNF therapy. Consequence or coincidence. A case-based reviewBonifacio Alvarez-Lario, Rosa Prieto-Tejedo, María Colazo-Burlato, et al.
European Journal of Rheumatology|November 3, 2018
Carbamazepine-induced systemic lupus erythematosus: A case-based reviewBonifacio Álvarez-Lario, Mónica Bártulos-Iglesias, María Colazo-Burlato, et al.
Reumatologia Clinica|November 20, 2021
Psoriatic arthritis: interaction between cardiometabolic diseases and inflammatory burden of the diseaseJosé Andrés Lorenzo Martín, Estefanía Pardo Campo, Marina Pino Martinez, et al.
Reumatologia Clinica|July 19, 2021
Psoriatic arthritis: interaction between cardiometabolic diseases and inflammatory burden of the diseaseJosé Andrés Lorenzo Martín, Estefanía Pardo Campo, Marina Pino Martinez, et al.
Modern Rheumatology Case Reports|September 7, 2021
Giant cell arteritis with spontaneous remissionBonifacio Álvarez-Lario, José Andrés Lorenzo-Martín, María Colazo-Burlato, et al.
Rheumatology (Oxford, England)|October 22, 2025
Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease modifying antirheumatic drugs: results from the BIOBADASER III registryJuan Molina-Collada, Lucía Otero-Varela, Paloma Vela, et al.
Journal of Autoimmunity|August 27, 2020
High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patientsEnrique Iglesias-Julián, María López-Veloso, Noelia de-la-Torre-Ferrera, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Rheumatology|May 14, 2013
Severe Guillain-Barré syndrome in a patient receiving anti-TNF therapy. Consequence or coincidence. A case-based reviewBonifacio Alvarez-Lario, Rosa Prieto-Tejedo, María Colazo-Burlato, et al.
European Journal of Rheumatology|November 3, 2018
Carbamazepine-induced systemic lupus erythematosus: A case-based reviewBonifacio Álvarez-Lario, Mónica Bártulos-Iglesias, María Colazo-Burlato, et al.
Reumatologia Clinica|November 20, 2021
Psoriatic arthritis: interaction between cardiometabolic diseases and inflammatory burden of the diseaseJosé Andrés Lorenzo Martín, Estefanía Pardo Campo, Marina Pino Martinez, et al.
Reumatologia Clinica|July 19, 2021
Psoriatic arthritis: interaction between cardiometabolic diseases and inflammatory burden of the diseaseJosé Andrés Lorenzo Martín, Estefanía Pardo Campo, Marina Pino Martinez, et al.
Modern Rheumatology Case Reports|September 7, 2021
Giant cell arteritis with spontaneous remissionBonifacio Álvarez-Lario, José Andrés Lorenzo-Martín, María Colazo-Burlato, et al.
Rheumatology (Oxford, England)|October 22, 2025
Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease modifying antirheumatic drugs: results from the BIOBADASER III registryJuan Molina-Collada, Lucía Otero-Varela, Paloma Vela, et al.
Journal of Autoimmunity|August 27, 2020
High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patientsEnrique Iglesias-Julián, María López-Veloso, Noelia de-la-Torre-Ferrera, et al.
Pageof 1